Craft

IMAC Regeneration Centers

Stock Price

$1.2

2024-10-29

Market Capitalization

$2.1 M

2024-10-29

Revenue

$72.1 K

FY, 2024

IMAC Regeneration Centers Summary

Company Summary

Overview
IMAC Regeneration is a provider of nonsurgical treatments and therapies for soft tissue damage and neurological diseases. It specializes in medical services that treat movement-restricted patients with knee pain, back pain, soft tissue, and joint damage, muscular tears, neurological diseases, and arthritis.
Type
Public
Status
Active
Founded
2000
HQ
Paducah, KY, US | view all locations
Website
https://imacregeneration.com/
Cybersecurity rating
Sectors

Key People

  • Jeffrey S. Ervin

    Jeffrey S. Ervin, Chief Executive Officer and Director

    • Cary Sucoff, Director

      • Matthew C. Wallis

        Matthew C. Wallis, Chief Operating Officer and Director

        • Mike Pruitt, Director

          Operating MetricsView all

          Patient Visits

          45K
          18.1%

          H1, 2018

          Average Cost of a Knee Treatment per Patient

          $4.2K

          FY, 2017

          Clinics

          11

          FY, 2018

          LocationsView all

          14 locations detected

          • Paducah, KY HQ

            United States

            2725 James Sanders Blvd

          • Bonita Springs, FL

            United States

            24830 S Tamiami Trail #1000

          • Brentwood, TN

            United States

            1605 Westgate Cir

          • Chesterfield, MO

            United States

            13353 Olive Blvd

          • Elgin, IL

            United States

            810 S McLean Blvd

          • Lexington, KY

            United States

            2537 Larkin Rd

          and 8 others

          IMAC Regeneration Centers Financials

          Summary Financials

          Revenue (Q3, 2025)
          $21.2K
          Gross profit (Q3, 2025)
          ($102.7K)
          Net income (Q3, 2025)
          ($3.1M)
          Cash (Q3, 2025)
          $45.1K
          EBIT (Q3, 2025)
          ($2.6M)
          Enterprise value
          $5.9M

          Footer menu